Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line PanelPhyllis A Svingen, David Loegering, Joe Rodriquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Cediranib for metastatic alveolar soft part sarcomaShivaani Kummar, Deborah Allen, Anne Monks, et al.
Journal of the National Cancer Institute|June 2, 2016
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA ExpressionEric Polley, Mark Kunkel, David Evans, et al.
Biochemical Pharmacology|July 16, 2017
Characterization of potent and selective iodonium-class inhibitors of NADPH oxidasesJiamo Lu, Prabhakar Risbood, Charles T Kane, et al.
Plos One|August 8, 2012
Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcomaVaibhav Saini, Curtis D Hose, Anne Monks, et al.
Oncotarget|October 22, 2021
ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomideLara H El Touny, Curtis Hose, John Connelly, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2009
Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]Andrew G Jobson, George T Lountos, Philip L Lorenzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignanciesShivaani Kummar, Robert Kinders, Martin E Gutierrez, et al.
Cancer Research|October 26, 2018
The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line PanelAnne Monks, Yingdong Zhao, Curtis Hose, et al.
Pageof 4